Discovery of Selective Nrf2 Activators from Natural Products: AComputational Screening Approach to Minimize Off-Target Effects on PXR and CYP2D6
Yue WangiD, Yiwen Gong, Ruofei Li, Zhiru LiiD, Hongxia CaiiD, Li FaniD, Yutong LiiD, Haomiao Ma
Abstract
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a central regulator of cellular antioxidant responses and a highly promising therapeutic target for a range of oxidative stress-related diseases. However, the clinical translation of Nrf2 activators has been hampered by significant off-target effects--notably unintended activation of the pregnane X receptor (PXR) and inhibition of cytochrome P450 2D6 (CYP2D6)--which can lead to dangerous drug-drug interactions and metabolic complications. To overcome this critical barrier, we conducted the first large-scale computational screening of 628,898 natural products from the COCONUT database, integrating molecular docking with a rigorous three-tier selectivity strategy designed to prioritize compounds that strongly bind KEAP1 (the primary Nrf2 repressor) while minimizing interactions with PXR and CYP2D6. Our innovative approach identified 10 ultraselective candidates that demonstrate potent KEAP1 affinity, negligible PXR engagement, and only moderate CYP2D6 binding--achieving up to 12.29-fold selectivity for Nrf2 pathway activation. These top hits are structurally novel, enriched in lipid-like and nucleoside-inspired scaffolds, and exhibit promising drug-like properties. By providing both a curated set of chemically diverse, selectivity-optimized leads and a publicly accessible screening dataset, this work establishes a new foundation for the rational development of safer, more precise Nrf2-targeted therapies, bridging a crucial gap between target potential and clinical viability. By prioritizing compounds with minimal off-target effects on PXR and CYP2D6, our approach offers a scalable template for reducing drug development failures and advancing safer therapeutics for oxidative stress-related diseases. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=124 SRC="FIGDIR/small/718057v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@13c6c79org.highwire.dtl.DTLVardef@1f5a078org.highwire.dtl.DTLVardef@fa4f4borg.highwire.dtl.DTLVardef@16bc881_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical abstractC_FLOATNO C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Drug targeting to sites of oxidative stress using the Baeyer-Villiger reaction
T. D. Avery, J. Li, … A. D. Abell·bioRxiv·Sep 3, 2021
- Pyrimethamine and a potent analogue WCDD115 inhibit NRF2 by suppressing DHFR and one-carbon metabolism
Julius Chembo, Brittany M. Bowman, … Michael B. Major·bioRxiv·Feb 13, 2025
- FUNCTIONAL ANALYSIS OF BIPARTITE NRF2 ACTIVATORS THAT OVERCOME FEEDBACK REGULATION FOR AGE-RELATED CHRONIC DISEASES
Dmitry M. Hushpulian, Navneet Ammal Kaidery, … Bobby Thomas·Redox BiologyPeer-reviewed·Jul 30, 2025
- The electrophilic metabolite of kynurenine, kynurenine-CKA, targets C151 in Keap1 to derepress Nrf2.
Jialin Feng, Mara Carreño, … Albena T. Dinkova‐Kostova·Redox BiologyPeer-reviewed·Jan 6, 2026
- Endogenous CGRP activates NRF2 signaling via non-electrophilic mechanisms
Keren Powell, Steven Wadolowski, … Chunyan Li·bioRxiv·Apr 25, 2025
- Curcumin activates distinct programming of redox metabolism towards differential regulation of gene expression mediated by Nrf1 and Nrf2
Reziyamu Wufuer, Feng Jing, … Yiguo Zhang·bioRxiv·Jul 9, 2025